A decade after Congress first allowed federal funding to support clean needle programs, the Trump administration is backing off that policy, potentially risking progress made against hepatitis C, a deadly but curable virus mostly spread by people who inject drugs.
The administration now says funding can no longer support programs such as paying the people who distribute syringes, framing it as “enabling” drug use.
